EUVIMEDEUVIMED entdecken
Fallbericht

EWSR1-SMAD3–rearranged fibroblastic tumor: a case report with literature review

Guanghong Yang, Zhenwei Chen, Yuanli Zhong, Liqian Hu, Baizhou Li

Medical Molecular Morphology · 27.07.2026

DOI: 10.1007/s00795-026-00471-5 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Medical Molecular Morphology, online erschienen am 27.07.2026. Verfasst von Guanghong Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper discusses an EWSR1-SMAD3-rearranged fibroblastic tumor (ESFT) occurring in the wrist of a 5-year-old child and summarizes its clinicopathological features, immunohistochemical phenotype, and molecular characteristics to improve the accuracy of clinical diagnosis. A retrospective analysis was performed on the clinical manifestations, histopathology, immunohistochemical phenotype, and molecular characteristics of a 5-year-old patient with recurrent ESFT. Additionally, this paper presents a literature review of relevant studies on ESFT. Among the 21 cases of ESFT, including the present case, the disease primarily affects young and middle-aged adult females, with most tumors measuring 1-2 cm in diameter. It preferentially occurs in the soft tissues of the distal extremities-particularly the foot-and exhibits low-grade invasiveness. Histomorphologically, the tumor is composed of uniform spindle-shaped fibroblasts arranged in fascicular and interlacing patterns, with no prominent nucleoli or mitotic figures. A zonation pattern, focal microcalcification, and interstitial myxoid change are observed in some cases. Immunohistochemistry reveals diffuse, strong ERG expression in tumor cells; FISH molecular detection shows EWSR1 break-apart; and NGS results confirm EWSR1-SMAD3 rearrangement. ESFT is a benign neoplasm with a risk of local recurrence. It exhibits complex histomorphological features but demonstrates diffuse, strong immunoreactivity for ERG on immunohistochemistry and harbors characteristic genetic alterations.

Schlagwörter

Stichwörter der Autor:innen

EWSR1Fibroblastic neoplasmGene rearrangementSMAD3Soft tissue neoplasm

Autor:innen und Institutionen

  • Department of Pathology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China.
  • Department of Pathology, The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, Zhejiang, China. libaizhou@zju.edu.cn.

Zitieren

APA

Yang, G., Chen, Z., Zhong, Y., Hu, L., & Li, B. (2026). EWSR1-SMAD3–rearranged fibroblastic tumor: a case report with literature review. Medical Molecular Morphology. https://doi.org/10.1007/s00795-026-00471-5

Vancouver

Yang G, Chen Z, Zhong Y, Hu L, Li B. EWSR1-SMAD3–rearranged fibroblastic tumor: a case report with literature review. Medical Molecular Morphology. 2026. doi:10.1007/s00795-026-00471-5

BibTeX
@article{Yang2026,
  author = {Yang, Guanghong and Chen, Zhenwei and Zhong, Yuanli and Hu, Liqian and Li, Baizhou},
  title = {EWSR1-SMAD3–rearranged fibroblastic tumor: a case report with literature review},
  journal = {Medical Molecular Morphology},
  year = {2026},
  doi = {10.1007/s00795-026-00471-5}
}
Kostenlos starten →